Alzheimer's blood biomarker tracks brain amyloid similarly across racial groups, study finds

A global study finds that a blood biomarker can effectively track brain amyloid levels across different racial groups in Alzheimer's clinical trials, supporting its use in screening cognitively unimpaired participants.